Welcome : Guest

Cerecor, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Cerecor, Inc., which is principally a Clinical-Stage Biopharmaceutical Company. Illustrated with 20 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65985
Price: $1000
Company Type: Public
Pages: 23
Date: January 2017
Market Data Tables: 20

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Central Nervous System (CNS)......4
Table 1: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......4
Table 2: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......5
Depression Drugs......6
Table 3: Depression Drugs Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Bupropion Hydrochloride XL, Cymbalta, Escitalopram Oxalate, Lexapro, Pristiq, and Others......6
Antipsychotic Drugs......7
Table 4: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......7
Table 5: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......8
Table 6: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......9
Epilepsy Therapeutics......10
Table 7: Epilepsy Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Carbamazepine Generics, Depakote/ER Franchise (ABT), Depakote/ER Generics, Dilant in (PFE), Gabapent in Generics, Keppra Generics, Keppra/XR (UCB), Lamictal/XR (GSK), Lyrica (PFE), Trileptal (NVS), Vimpat (UCB), and Others......10
Parkinson's......11
Table 8: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......11
Table 9: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......12
Smoking Cessation......13
Table 10: Smoking Cessation Market by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Italy, Japan, Spain, UK, US, and Rest of World......13
Table 11: Nicotine Replacement Therapy (NRT) Smoking Cessation Market by Product Worldwide (2015) - Percentage Share Breakdown by Value Sales for Gum, Patches, Tablets or Lozenges, and Others......14
Table 12: Global Smoking Cessation (Nicotine Replacement Therapy & Prescription Drugs) Market (2014) in US$ Million......15
Central Nervous System (CNS) Medicines......16
Table 13: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......16
Table 14: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......17
Antipsychotic Drugs......18
Table 15: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......18
Table 16: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......19
Table 17: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......20
Table 18: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......21
Epilepsy Therapeutics......22
Table 19: Market Shares of Leading Epilepsy Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......22
Post-Traumatic Stress Disorder (PTSD)......23
Table 20: Market Shares of Leading Drugs for Post-Traumatic Stress Disorder (PTSD) Treatment in the US (2015) - Percentage Share Breakdown by Value for Citalopram, Clonazepam, Escitalopram, Quetiapine, Quetiapine, Sertraline, and Others......23